Corporate insider
Khan Najat
Director, Chief R&D Commercial OfficerCIK 0002020969
Disclosed transactions6
Buys / sells0 / 1
Max Insider Score23
Connections with evidence1
Disclosed transactions
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 11 | Khan NajatDirector, CEO and President |  RXRXRECURSION PHARMACEUTICALS, INC.Tax withholding | F | $254K 80.5K sh | Aug 18, 2026 traded Aug 17, 2026 | |
Verified connections
- Insider ofevidenceRECURSION PHARMACEUTICALS, INC.Director, Chief R&D Commercial Officer · Nov 6, 2025